<?xml version="1.0" encoding="ISO-8859-1"?><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<front>
<journal-meta>
<journal-id>1688-0390</journal-id>
<journal-title><![CDATA[Revista Médica del Uruguay]]></journal-title>
<abbrev-journal-title><![CDATA[Rev. Méd. Urug.]]></abbrev-journal-title>
<issn>1688-0390</issn>
<publisher>
<publisher-name><![CDATA[Sindicato Médico del Uruguay]]></publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id>S1688-03902025000101203</article-id>
<article-id pub-id-type="doi">10.29193/rmu.41.1.4</article-id>
<title-group>
<article-title xml:lang="es"><![CDATA[Cáncer de orofaringe en Uruguay. Análisis de sobrevida en pacientes estadio III y IV tratados con radioterapia]]></article-title>
<article-title xml:lang="en"><![CDATA[Oropharyngeal cancer in Uruguay: Survival analysis in stage III and IV patients treated with radiotherapy]]></article-title>
<article-title xml:lang="pt"><![CDATA[Câncer de orofaringe no Uruguai: Análise de sobrevida em pacientes nos estágios III e IV tratados com radioterapia]]></article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Ríos]]></surname>
<given-names><![CDATA[Rodrigo]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Ferrer]]></surname>
<given-names><![CDATA[Joaquin]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Rosich]]></surname>
<given-names><![CDATA[Agustin]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Torres]]></surname>
<given-names><![CDATA[Marcelo]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Rivero]]></surname>
<given-names><![CDATA[Emiliano]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Roldan]]></surname>
<given-names><![CDATA[Santiago]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Guerreros]]></surname>
<given-names><![CDATA[Sofia]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Munyo]]></surname>
<given-names><![CDATA[Andres]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Borche]]></surname>
<given-names><![CDATA[German]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[D&#8217;Albora]]></surname>
<given-names><![CDATA[Ricardo]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Ricagni]]></surname>
<given-names><![CDATA[Leandro]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Lorenzo]]></surname>
<given-names><![CDATA[Federico]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
</contrib-group>
<aff id="Af1">
<institution><![CDATA[,Universidad de la República Facultad de Medicina ]]></institution>
<addr-line><![CDATA[Montevideo ]]></addr-line>
<country>Uruguay</country>
</aff>
<aff id="Af2">
<institution><![CDATA[,Universidad de la República Facultad de Ciencias Económicas y de Administración ]]></institution>
<addr-line><![CDATA[Montevideo ]]></addr-line>
<country>Uruguay</country>
</aff>
<pub-date pub-type="pub">
<day>00</day>
<month>12</month>
<year>2025</year>
</pub-date>
<pub-date pub-type="epub">
<day>00</day>
<month>12</month>
<year>2025</year>
</pub-date>
<volume>41</volume>
<numero>1</numero>
<copyright-statement/>
<copyright-year/>
<self-uri xlink:href="http://www.scielo.edu.uy/scielo.php?script=sci_arttext&amp;pid=S1688-03902025000101203&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://www.scielo.edu.uy/scielo.php?script=sci_abstract&amp;pid=S1688-03902025000101203&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://www.scielo.edu.uy/scielo.php?script=sci_pdf&amp;pid=S1688-03902025000101203&amp;lng=en&amp;nrm=iso"></self-uri><abstract abstract-type="short" xml:lang="es"><p><![CDATA[Resumen  Introducción: El cáncer de orofaringe es una neoplasia con alta incidencia en cabeza y cuello. A pesar de presentarse en un sitio de fácil visibilidad al examen físico y a los avances en su diagnóstico, el cáncer de orofaringe suele detectarse en etapas avanzadas. Como principales estrategias terapéuticas, en el contexto de la enfermedad avanzada, se pueden plantear como tratamientos la cirugía y/o la radioterapia.  Metodología: El objetivo de este estudio fue analizar la sobrevida de pacientes con cáncer de orofaringe en estado avanzado (estadios III y IV del TNM) que recibieron tratamiento pretendidamente curativo con radioterapia. Se estudiaron 31 pacientes pertenecientes al Hospital de Clínicas Dr. Manuel Quintela, que fueron valorados en las policlínicas de radioterapia y otorrinolaringología entre 2013 y 2022.  Resultados: Los pacientes fueron en su mayoría tabaquistas, alcoholistas, de sexo masculino, con un promedio de edad de 60 años. Fue observada una tasa de sobrevida global a los 5 años del 67,7% (47,6 &#8211; 84,9 IC 95%). La media de sobrevida global a los 5 años fue de 66,3 meses (47,6 &#8211; 84,9 IC 95%). La mediana de sobrevida global no fue alcanzada en el estudio. La persistencia de la enfermedad después del tratamiento con radioterapia fue el único factor que tuvo una influencia significativa en la sobrevida. El análisis univariado mediante Log-Rank evidenció una media de 92,3 meses (77,9 &#8211; 106,7 IC 95%) para pacientes sin persistencia de la enfermedad vs. 7,5 meses (4,9 - 10 IC 95%) con una mediana de 8 meses (3 &#8211; 12,9 IC 95%) para pacientes con persistencia de la enfermedad (p&lt; 0,001).  Conclusiones: La sobrevida observada puede ser debido al número reducido de pacientes incluidos en el estudio. La respuesta incompleta del tumor al tratamiento demostró ser el factor de mayor relevancia en la sobrevida. El seguimiento de estos pacientes es de suma importancia dado que todos los fallecimientos fueron registrados dentro de los primeros 24 meses luego del diagnóstico.]]></p></abstract>
<abstract abstract-type="short" xml:lang="en"><p><![CDATA[Abstract  Introduction: Oropharyngeal cancer is a neoplasm with a high incidence in the head and neck region. Despite its location being easily visible during physical examination and advances in its diagnosis, oropharyngeal cancer is often detected at advanced stages. As primary therapeutic strategies, in the context of advanced disease, surgery and/or radiotherapy may be considered as treatments.  Methodology: The aim of this study was to analyze the survival of patients with advanced oropharyngeal cancer (stages III and IV of the TNM) who received intended curative treatment with radiotherapy. Thirty-one patients from the Dr. Manuel Quintela Clinics Hospital, who were evaluated in the radiotherapy and otolaryngology clinics between 2013 and 2022, were studied.  Results: The patients were mostly smokers, alcoholics, male, with an average age of 60 years. A 5-year overall survival rate of 67,7% (95% CI 47,6 &#8211; 84,9) was observed. The mean overall survival at 5 years was 66,3 months (95% CI 47,6 &#8211; 84,9). The median overall survival was not reached in the study. Disease persistence after radiotherapy treatment was the only factor that significantly influenced survival. Univariate analysis using Log-Rank showed a mean of 92,3 months (95% CI 77,9 - 106,7) for patients without disease persistence vs. 7,5 months (95% CI 4,9 - 10) with a median of 8 months (95% CI 3 - 12,9) for patients with disease persistence (p&lt; 0,001).  Conclusions: The observed survival may be due to the small number of patients included in the study. Incomplete tumor response to treatment proved to be the most relevant factor in survival. The follow-up of these patients is of utmost importance since all deaths were recorded within the first 24 months after diagnosis.]]></p></abstract>
<abstract abstract-type="short" xml:lang="pt"><p><![CDATA[Resumo  Introdução: O câncer de orofaringe é uma neoplasia com alta incidência em cabeça e pescoço. Apesar de ocorrer em uma região de fácil visibilidade no exame físico e dos avanços no diagnóstico, o câncer de orofaringe geralmente é detectado em estágios avançados. Como principais estratégias terapêuticas no contexto da doença avançada, podem ser considerados tratamentos como cirurgia e/ou radioterapia.  Metodologia: O objetivo deste estudo foi analisar a sobrevida de pacientes com câncer de orofaringe em estágio avançado (estágios III e IV do TNM) que receberam tratamento com intenção curativa por meio de radioterapia. Foram analisados 31 pacientes do Hospital de Clínicas Dr. Manuel Quintela, avaliados nas policlínicas de radioterapia e otorrinolaringologia entre 2013 e 2022.  Resultados: A maioria dos pacientes era tabagista, alcoólatra, do sexo masculino, com idade média de 60 anos. Foi observada uma taxa de sobrevida global em 5 anos de 67,7% (47,6 &#8211; 84,9 IC 95%). A média de sobrevida global em 5 anos foi de 66,3 meses (47,6 &#8211; 84,9 IC 95%). A mediana de sobrevida global não foi atingida no estudo. A persistência da doença após o tratamento com radioterapia foi o único fator que teve influência significativa na sobrevida. A análise univariada por meio do Log-Rank evidenciou uma média de 92,3 meses (77,9 &#8211; 106,7 IC 95%) para pacientes sem persistência da doença vs. 7,5 meses (4,9 - 10 IC 95%) com uma mediana de 8 meses (3 &#8211; 12,9 IC 95%) para pacientes com persistência da doença (p&lt; 0,001).  Conclusões: A sobrevida observada pode ser explicada pelo número reduzido de pacientes incluídos no estudo. A resposta incompleta do tumor ao tratamento demonstrou ser o fator de maior relevância na sobrevida. O acompanhamento desses pacientes é de extrema importância, considerando que todos os óbitos foram registrados nos primeiros 24 meses após o diagnóstico.]]></p></abstract>
<kwd-group>
<kwd lng="es"><![CDATA[Neoplasias orofaríngeas]]></kwd>
<kwd lng="es"><![CDATA[Radioterapia]]></kwd>
<kwd lng="es"><![CDATA[Supervivencia]]></kwd>
<kwd lng="en"><![CDATA[Oropharyngeal neoplasms]]></kwd>
<kwd lng="en"><![CDATA[Radiotherapy]]></kwd>
<kwd lng="en"><![CDATA[Survival]]></kwd>
<kwd lng="pt"><![CDATA[Neoplasias orofaringeanas]]></kwd>
<kwd lng="pt"><![CDATA[Radioterapia]]></kwd>
<kwd lng="pt"><![CDATA[Sobrevivência]]></kwd>
</kwd-group>
</article-meta>
</front><back>
<ref-list>
<ref id="B1">
<label>1.</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Rettig]]></surname>
<given-names><![CDATA[EM]]></given-names>
</name>
<name>
<surname><![CDATA[D&#8217;Souza]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Epidemiology of head and neck cancer]]></article-title>
<source><![CDATA[Surg Oncol Clin N Am]]></source>
<year>2015</year>
<volume>24</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>379-96</page-range></nlm-citation>
</ref>
<ref id="B2">
<label>2.</label><nlm-citation citation-type="journal">
<collab>Comisión Honoraria de Lucha Contra el Cáncer (CHLCC)</collab>
<article-title xml:lang=""><![CDATA[Resumen estadístico &#8211; TODOS LOS CÁNCERES. Incidencia y Mortalidad periodo 2015-2019]]></article-title>
<source><![CDATA[Tendencia de la Mortalidad hasta]]></source>
<year>2020</year>
</nlm-citation>
</ref>
<ref id="B3">
<label>3.</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Barrios]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Musetti]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Alonso]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Garau]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[VI Atlas de mortalidad por cáncer en el Uruguay]]></article-title>
<source><![CDATA[Periodo 2014-2018]]></source>
<year>2022</year>
<publisher-loc><![CDATA[Montevideo ]]></publisher-loc>
<publisher-name><![CDATA[Comisión Honoraria de Lucha Contra el Cáncer]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B4">
<label>4.</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Patterson]]></surname>
<given-names><![CDATA[RH]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Global burden of head and neck cancer: economic consequences, health, and the role of surgery]]></article-title>
<source><![CDATA[Otolaryngol Head Neck Surg]]></source>
<year>2020</year>
<volume>162</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>296-303</page-range></nlm-citation>
</ref>
<ref id="B5">
<label>5.</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Rahimi]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[HPV-Related Squamous Cell Carcinoma of Oropharynx: A Review]]></article-title>
<source><![CDATA[J Clin Pathol]]></source>
<year>2020</year>
<volume>73</volume>
<numero>10</numero>
<issue>10</issue>
<page-range>624-9</page-range></nlm-citation>
</ref>
<ref id="B6">
<label>6.</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[O&#8217;Sullivan]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
<name>
<surname><![CDATA[Huang]]></surname>
<given-names><![CDATA[SH]]></given-names>
</name>
<name>
<surname><![CDATA[Su]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Garden]]></surname>
<given-names><![CDATA[AS]]></given-names>
</name>
<name>
<surname><![CDATA[Sturgis]]></surname>
<given-names><![CDATA[EM]]></given-names>
</name>
<name>
<surname><![CDATA[Dahlstrom]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[development and validation of a staging system for hpv-related oropharyngeal cancer by the international collaboration on oropharyngeal cancer network for staging (ICON-S): A Multicentre Cohort Study]]></article-title>
<source><![CDATA[Lancet Oncol]]></source>
<year>2016</year>
<volume>17</volume>
<numero>4</numero>
<issue>4</issue>
<page-range>440-51</page-range></nlm-citation>
</ref>
<ref id="B7">
<label>7.</label><nlm-citation citation-type="">
<collab>NCCN Clinical Practice Guidelines</collab>
<source><![CDATA[Head and Neck Cancers]]></source>
<year></year>
</nlm-citation>
</ref>
<ref id="B8">
<label>8.</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Hoffmann]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Saleh-Ebrahimi]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Zwicker]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
<name>
<surname><![CDATA[Haering]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Schwahofer]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Debus]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Long term results of postoperative Intensity-Modulated Radiation Therapy (IMRT) in the treatment of Squamous Cell Carcinoma (SCC) located in the oropharynx or oral cavity]]></article-title>
<source><![CDATA[Radiat Oncol]]></source>
<year>2015</year>
<volume>10</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>251</page-range></nlm-citation>
</ref>
<ref id="B9">
<label>9.</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Alterio]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Gugliandolo]]></surname>
<given-names><![CDATA[SG]]></given-names>
</name>
<name>
<surname><![CDATA[Augugliaro]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Marvaso]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Gandini]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Bellerba]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[IMRT versus 2D/3D conformal RT in oropharyngeal cancer: A review of the literature and meta-analysis]]></article-title>
<source><![CDATA[Oral Dis]]></source>
<year>2021</year>
<volume>27</volume>
<numero>7</numero>
<issue>7</issue>
<page-range>1644-53</page-range></nlm-citation>
</ref>
<ref id="B10">
<label>10.</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Sjövall]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Chua]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
<name>
<surname><![CDATA[Pryor]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Burmeister]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Foote]]></surname>
<given-names><![CDATA[MC]]></given-names>
</name>
<name>
<surname><![CDATA[Panizza]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Long-term results of positron emission tomography-directed management of the neck in node-positive head and neck cancer after organ preservation therapy]]></article-title>
<source><![CDATA[Oral Oncol]]></source>
<year>2015</year>
<volume>51</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>260-6</page-range></nlm-citation>
</ref>
<ref id="B11">
<label>11.</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Ng]]></surname>
<given-names><![CDATA[SP]]></given-names>
</name>
<name>
<surname><![CDATA[Pollard]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Berends]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Ayoub]]></surname>
<given-names><![CDATA[Z]]></given-names>
</name>
<name>
<surname><![CDATA[Kamal]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Garden]]></surname>
<given-names><![CDATA[AS]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Usefulness of surveillance imaging in patients with head and neck cancer who are treated with definitive radiotherapy: imaging in patients with head and neck cancer]]></article-title>
<source><![CDATA[Cancer]]></source>
<year>2019</year>
<volume>125</volume>
<numero>11</numero>
<issue>11</issue>
<page-range>1823-9</page-range></nlm-citation>
</ref>
<ref id="B12">
<label>12.</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Kao]]></surname>
<given-names><![CDATA[SS]]></given-names>
</name>
<name>
<surname><![CDATA[Ooi]]></surname>
<given-names><![CDATA[EH]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Survival outcomes following salvage surgery for oropharyngeal squamous cell carcinoma: Systematic review]]></article-title>
<source><![CDATA[J Laryngol Otol]]></source>
<year>2018</year>
<volume>132</volume>
<numero>4</numero>
<issue>4</issue>
<page-range>299-313</page-range></nlm-citation>
</ref>
<ref id="B13">
<label>13.</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Yeh]]></surname>
<given-names><![CDATA[DH]]></given-names>
</name>
<name>
<surname><![CDATA[Tam]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Fung]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
<name>
<surname><![CDATA[MacNeil]]></surname>
<given-names><![CDATA[SD]]></given-names>
</name>
<name>
<surname><![CDATA[Yoo]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Winquist]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Transoral robotic surgery vs. radiotherapy for management of oropharyngeal squamous cell carcinoma - A systematic review of the literature]]></article-title>
<source><![CDATA[Eur J Surg Oncol]]></source>
<year>2015</year>
<volume>41</volume>
<numero>12</numero>
<issue>12</issue>
<page-range>1603-14</page-range></nlm-citation>
</ref>
<ref id="B14">
<label>14.</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Ferris]]></surname>
<given-names><![CDATA[RL]]></given-names>
</name>
<name>
<surname><![CDATA[Flamand]]></surname>
<given-names><![CDATA[Y]]></given-names>
</name>
<name>
<surname><![CDATA[Weinstein]]></surname>
<given-names><![CDATA[GS]]></given-names>
</name>
<name>
<surname><![CDATA[Li]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Quon]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
<name>
<surname><![CDATA[Mehra]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Phase II randomized trial of transoral surgery and low-dose intensity modulated radiation therapy in resectable p16+ locally advanced oropharynx cancer: An ECOG-ACRIN cancer research group trial (E3311)]]></article-title>
<source><![CDATA[J Clin Oncol]]></source>
<year>2022</year>
<volume>40</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>138-49</page-range></nlm-citation>
</ref>
<ref id="B15">
<label>15.</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Roman]]></surname>
<given-names><![CDATA[BR]]></given-names>
</name>
<name>
<surname><![CDATA[Goldenberg]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Givi]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[AHNS Series--Do you know your guidelines? Guideline recommended follow-up and surveillance of head and neck cancer survivors: AHNS Series-NCCN guidelines for follow-up and surveillance]]></article-title>
<source><![CDATA[Head Neck]]></source>
<year>2016</year>
<volume>38</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>168-74</page-range></nlm-citation>
</ref>
<ref id="B16">
<label>16.</label><nlm-citation citation-type="">
<collab>National Cancer Institute</collab>
<source><![CDATA[Cancer Statistics: NIH Surveillance Epidemiology, and End Results Program]]></source>
<year></year>
</nlm-citation>
</ref>
<ref id="B17">
<label>17.</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Anantharaman]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Billot]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Waterboer]]></surname>
<given-names><![CDATA[T]]></given-names>
</name>
<name>
<surname><![CDATA[Gheit]]></surname>
<given-names><![CDATA[T]]></given-names>
</name>
<name>
<surname><![CDATA[Abedi-Ardekani]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
<name>
<surname><![CDATA[Lagiou]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Predictors of oropharyngeal cancer survival in Europe]]></article-title>
<source><![CDATA[Oral Oncol]]></source>
<year>2018</year>
<volume>81</volume>
<page-range>89-94</page-range></nlm-citation>
</ref>
<ref id="B18">
<label>18.</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Kowalski]]></surname>
<given-names><![CDATA[LP]]></given-names>
</name>
<name>
<surname><![CDATA[Oliveira]]></surname>
<given-names><![CDATA[MM de]]></given-names>
</name>
<name>
<surname><![CDATA[Lopez]]></surname>
<given-names><![CDATA[RVM]]></given-names>
</name>
<name>
<surname><![CDATA[Silva]]></surname>
<given-names><![CDATA[DRM]]></given-names>
</name>
<name>
<surname><![CDATA[Ikeda]]></surname>
<given-names><![CDATA[MK]]></given-names>
</name>
<name>
<surname><![CDATA[Curado]]></surname>
<given-names><![CDATA[MP]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Survival trends of patients with oral and oropharyngeal cancer treated at a cancer center in São Paulo, Brazil]]></article-title>
<source><![CDATA[Clinics]]></source>
<year>2020</year>
<volume>75</volume>
<page-range>e1507</page-range></nlm-citation>
</ref>
<ref id="B19">
<label>19.</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Caldeira]]></surname>
<given-names><![CDATA[PC]]></given-names>
</name>
<name>
<surname><![CDATA[Bonardi]]></surname>
<given-names><![CDATA[MJF]]></given-names>
</name>
<name>
<surname><![CDATA[Pantuzzo]]></surname>
<given-names><![CDATA[ERM]]></given-names>
</name>
<name>
<surname><![CDATA[Soares]]></surname>
<given-names><![CDATA[JMA]]></given-names>
</name>
<name>
<surname><![CDATA[Soto]]></surname>
<given-names><![CDATA[AML]]></given-names>
</name>
<name>
<surname><![CDATA[Aguiar]]></surname>
<given-names><![CDATA[MCF]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Advanced carcinoma of the oropharynx: Survival analysis comparing two treatment modalities]]></article-title>
<source><![CDATA[Braz Oral Res]]></source>
<year>2020</year>
<volume>34</volume>
<page-range>e032</page-range></nlm-citation>
</ref>
<ref id="B20">
<label>20.</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Simon]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Goepfert]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
<name>
<surname><![CDATA[Rosenthal]]></surname>
<given-names><![CDATA[DI]]></given-names>
</name>
<name>
<surname><![CDATA[Roberts]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[El-Naggar]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Old]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Presence of malignant tumor cells in persistent neck disease after radiotherapy for advanced squamous cell carcinoma of the oropharynx is associated with poor survival]]></article-title>
<source><![CDATA[Eur Arch Otorhinolaryngol]]></source>
<year>2006</year>
<volume>263</volume>
<numero>4</numero>
<issue>4</issue>
<page-range>313-8</page-range></nlm-citation>
</ref>
<ref id="B21">
<label>21.</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Patel]]></surname>
<given-names><![CDATA[SN]]></given-names>
</name>
<name>
<surname><![CDATA[Cohen]]></surname>
<given-names><![CDATA[MA]]></given-names>
</name>
<name>
<surname><![CDATA[Givi]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
<name>
<surname><![CDATA[Dixon]]></surname>
<given-names><![CDATA[BJ]]></given-names>
</name>
<name>
<surname><![CDATA[Gilbert]]></surname>
<given-names><![CDATA[RW]]></given-names>
</name>
<name>
<surname><![CDATA[Gullane]]></surname>
<given-names><![CDATA[PJ]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Salvage surgery for locally recurrent oropharyngeal cancer: Salvage surgery for locally recurrent oropharyngeal cancer]]></article-title>
<source><![CDATA[Head Neck]]></source>
<year>2016</year>
<volume>38</volume>
<numero>S1</numero>
<issue>S1</issue>
<page-range>E658-64</page-range></nlm-citation>
</ref>
<ref id="B22">
<label>22.</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Jayaram]]></surname>
<given-names><![CDATA[SC]]></given-names>
</name>
<name>
<surname><![CDATA[Muzaffar]]></surname>
<given-names><![CDATA[SJ]]></given-names>
</name>
<name>
<surname><![CDATA[Ahmed]]></surname>
<given-names><![CDATA[I]]></given-names>
</name>
<name>
<surname><![CDATA[Dhanda]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Paleri]]></surname>
<given-names><![CDATA[V]]></given-names>
</name>
<name>
<surname><![CDATA[Mehanna]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Efficacy, outcomes, and complication rates of different surgical and nonsurgical treatment modalities for recurrent/residual oropharyngeal carcinoma: A systematic review and meta-analysis: Oropharyngeal Cancer Treatment Survival Outcomes]]></article-title>
<source><![CDATA[Head Neck]]></source>
<year>2016</year>
<volume>38</volume>
<numero>12</numero>
<issue>12</issue>
<page-range>1855-61</page-range></nlm-citation>
</ref>
<ref id="B23">
<label>23.</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Van Weert]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Leemans]]></surname>
<given-names><![CDATA[CR]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Salvage surgery in head and neck cancer]]></article-title>
<source><![CDATA[Oral Dis]]></source>
<year>2021</year>
<volume>27</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>117-24</page-range></nlm-citation>
</ref>
<ref id="B24">
<label>24.</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Trufelli]]></surname>
<given-names><![CDATA[DC]]></given-names>
</name>
<name>
<surname><![CDATA[Matos]]></surname>
<given-names><![CDATA[LL]]></given-names>
</name>
<name>
<surname><![CDATA[Santana]]></surname>
<given-names><![CDATA[TA]]></given-names>
</name>
<name>
<surname><![CDATA[Capelli]]></surname>
<given-names><![CDATA[F de A]]></given-names>
</name>
<name>
<surname><![CDATA[Kanda]]></surname>
<given-names><![CDATA[JL]]></given-names>
</name>
<name>
<surname><![CDATA[Del Giglio]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Complete pathologic response as a prognostic factor for squamous cell carcinoma of the oropharynx postchemoradiotherapy]]></article-title>
<source><![CDATA[Braz J Otorhinolaryngol]]></source>
<year>2015</year>
<volume>81</volume>
<numero>5</numero>
<issue>5</issue>
<page-range>498-504</page-range></nlm-citation>
</ref>
<ref id="B25">
<label>25.</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Álvarez Arias]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Munyo Estefan]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Borche]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[D&#8217;Albora]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Rodríguez Sande]]></surname>
<given-names><![CDATA[V]]></given-names>
</name>
<name>
<surname><![CDATA[Cuello]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Cáncer de cabeza y cuello en Uruguay. Análisis de sobrevida en dos centros de referencia]]></article-title>
<source><![CDATA[Rev Med Urug]]></source>
<year>2018</year>
<volume>34</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>42-63</page-range></nlm-citation>
</ref>
<ref id="B26">
<label>26.</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Emami]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Tolerance of normal tissue to therapeutic radiation]]></article-title>
<source><![CDATA[Rep Radiother Oncol]]></source>
<year>2013</year>
<volume>1</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>123-7</page-range></nlm-citation>
</ref>
<ref id="B27">
<label>27.</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Denis]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
<name>
<surname><![CDATA[Garaud]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Bardet]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Alfonsi]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Sire]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Germain]]></surname>
<given-names><![CDATA[T]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Final results of the 94-01 French Head and Neck Oncology and Radiotherapy Group randomized trial comparing radiotherapy alone with concomitant radiochemotherapy in advanced-stage oropharynx carcinoma]]></article-title>
<source><![CDATA[J Clin Oncol]]></source>
<year>2004</year>
<volume>22</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>69-76</page-range></nlm-citation>
</ref>
<ref id="B28">
<label>28.</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Ang]]></surname>
<given-names><![CDATA[KK]]></given-names>
</name>
<name>
<surname><![CDATA[Zhang]]></surname>
<given-names><![CDATA[Q]]></given-names>
</name>
<name>
<surname><![CDATA[Rosenthal]]></surname>
<given-names><![CDATA[DI]]></given-names>
</name>
<name>
<surname><![CDATA[Nguyen-Tan]]></surname>
<given-names><![CDATA[PF]]></given-names>
</name>
<name>
<surname><![CDATA[Sherman]]></surname>
<given-names><![CDATA[EJ]]></given-names>
</name>
<name>
<surname><![CDATA[Weber]]></surname>
<given-names><![CDATA[RS]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Randomized phase III trial of concurrent accelerated radiation plus cisplatin with or without cetuximab for stage III to IV head and neck carcinoma: RTOG 0522]]></article-title>
<source><![CDATA[J Clin Oncol]]></source>
<year>2014</year>
<volume>32</volume>
<numero>27</numero>
<issue>27</issue>
<page-range>2940-50</page-range></nlm-citation>
</ref>
<ref id="B29">
<label>29.</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Calais]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Alfonsi]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Bardet]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Sire]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Germain]]></surname>
<given-names><![CDATA[T]]></given-names>
</name>
<name>
<surname><![CDATA[Bergerot]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Stage III and IV cancers of the oropharynx: results of a randomized study of Gortec comparing radiotherapy alone with concomitant chemotherapy]]></article-title>
<source><![CDATA[Bull Cancer]]></source>
<year>2000</year>
<volume>87</volume>
</nlm-citation>
</ref>
<ref id="B30">
<label>30.</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Jensen]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
<name>
<surname><![CDATA[Friborg]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Hansen]]></surname>
<given-names><![CDATA[CR]]></given-names>
</name>
<name>
<surname><![CDATA[Samsøe]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Johansen]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Andersen]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[The Danish Head and Neck Cancer Group (DAHANCA) 2020 radiotherapy guidelines]]></article-title>
<source><![CDATA[Radiother Oncol]]></source>
<year>2020</year>
<volume>151</volume>
<page-range>149-51</page-range></nlm-citation>
</ref>
<ref id="B31">
<label>31.</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Fogliata]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Cozzi]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Bieri]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Bernier]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Critical appraisal of a conformal head and neck cancer irradiation avoiding electron beams and field matching]]></article-title>
<source><![CDATA[Int J Radiat Oncol Biol Phys]]></source>
<year>1999</year>
<volume>45</volume>
<numero>5</numero>
<issue>5</issue>
<page-range>1331-8</page-range></nlm-citation>
</ref>
<ref id="B32">
<label>32.</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Hanan]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[AE]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[EHF]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[IM]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Study and analysis of the conformation number and the integral dose as evaluation tools in head and neck tumors: for advanced 3-dimensional conformal radiation therapy techniques]]></article-title>
<source><![CDATA[Curr Trends Oncol Int J]]></source>
<year>2020</year>
<volume>17</volume>
<numero>4</numero>
<issue>4</issue>
<page-range>001-16</page-range></nlm-citation>
</ref>
</ref-list>
</back>
</article>
